Key Takeaways
- In 2021, approximately 10.4 million people aged 12 or older misused oxycodone in the past year in the US
- Oxycodone was involved in 15,289 overdose deaths in the US in 2021, representing about 14% of all prescription opioid-involved deaths
- From 2010 to 2020, the rate of oxycodone prescriptions per 100 people decreased by 62%, from 7.4 to 2.8
- White non-Hispanic adults have the highest oxycodone misuse rates at 2.1% past year
- Males aged 18-25 have oxycodone misuse rates 1.8 times higher than females
- Rural residents are 25% more likely to develop oxycodone use disorder than urban
- Oxycodone addiction increases risk of respiratory depression by 10-fold
- Chronic oxycodone use leads to tolerance in 80% of users within 3 months
- Oxycodone overdose causes hypoxic brain injury in 40% of survivors
- Buprenorphine treatment retention for oxycodone addiction is 55% at 6 months
- Methadone maintenance achieves 70% reduction in oxycodone use among addicts
- Cognitive behavioral therapy yields 50% abstinence rate at 12 months for oxycodone OUD
- Oxycodone addiction costs the US $78 billion annually in healthcare expenses
- Lost productivity from oxycodone OUD totals $50 billion yearly in US
- Each oxycodone overdose costs $48,000 in medical and emergency response
Oxycodone addiction affects millions and causes widespread, often fatal, overdoses.
Demographic Trends
Demographic Trends Interpretation
Health and Medical Consequences
Health and Medical Consequences Interpretation
Prevalence and Usage Statistics
Prevalence and Usage Statistics Interpretation
Socioeconomic Impacts
Socioeconomic Impacts Interpretation
Treatment and Recovery Data
Treatment and Recovery Data Interpretation
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2CDCcdc.govVisit source
- Reference 3NIDAnida.nih.govVisit source
- Reference 4DEAdea.govVisit source
- Reference 5NCBIncbi.nlm.nih.govVisit source
- Reference 6BRADFORDHEALTHbradfordhealth.comVisit source
- Reference 7JAMANETWORKjamanetwork.comVisit source
- Reference 8VAva.govVisit source
- Reference 9ASPEaspe.hhs.govVisit source
- Reference 10KFFkff.orgVisit source
- Reference 11NEJMnejm.orgVisit source
- Reference 12HUDUSERhuduser.govVisit source






